I. The Industry Has More Data Than Vision Biotechnology has become extraordinarily good at seeing the small. It can sequence a tumor, profile a transcriptome, quantify protein expression, monitor oxygen transfer, measure immune activation, model binding affinity, and predict structure at a level of resolution that would have seemed impossible a generation ago. It can […]
Tag: CRO
Biotech in 2026: The Real Bottlenecks in Scale-Up, Manufacturing, Capital, and Regulation
Where Biotech Actually Fails: Scale Is Not an Extension of the Lab Biotech still tells itself that scale is a later problem. In biotech in 2026, that belief is no longer naive — it is actively dangerous. The lab works.The data looks good.The organism behaves.The molecule binds.The titer hits the slide. And somewhere between that […]
THE TOPOLOGY OF ROUTING: Why Biomanufacturing Fails Without Maps, Meaning, and Precision Language
I. The Invisible Problem: Biomanufacturing Fails at the Edges Biomanufacturing does not fail in the clean, brightly lit parts of the process. It fails in the margins — the boundaries where one domain touches another and no single actor feels responsible for the distortion that happens there. Everyone in the industry believes they understand the […]